About: How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?
Creator	John, Joseph Mohindra, Ritin Suri, Vikas Bhalla, Ashish Malhotra, • Mahapatra, Manoranjan Deepesh Lad, • Dhawan, Rishi Jain, Arihant Jindal, • Khadwal, Alka Kumari, Savita Prakash, Gaurav Singh, Charanpreet Varma, •
source	Medline; PMC
abstract	The current pandemic coronavirus, SARS-CoV-2, is known to cause severe infection (COVID-19) in patients with comorbidities, particularly cancer or an immunosuppressed state. Most healthcare systems in the country are likely to be overwhelmed soon if the pandemic moves to a stage of community transmission. Currently, limited evidence is available for managing patients with hematological disorders during the COVID-19 pandemic. The current review summarises the possible challenges clinicians are likely to face, key considerations to guide decision making, and possible solutions to the anticipated challenges. Disease specific recommendations and possible guidance for decision making have been suggested for most hematologic diseases that are feasible in our health setup. It is not meant to replace individual clinical judgment, but to provide a template to formulate local policies.
has issue date	2020-06-06(xsd:dateTime)
bibo:doi	10.1007/s12288-020-01300-0
bibo:pmid	32837051
has license	no-cc
sha1sum (hex)	61abc6624e4d7b6cb7b53d4e12a0a59061fc2673
schema:url	https://doi.org/10.1007/s12288-020-01300-0
resource representing a document's title	How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?
has PubMed Central identifier	PMC7274942
has PubMed identifier	32837051
schema:publication	Indian J Hematol Blood Transfus
resource representing a document's body	covid:61abc6624e4d7b6cb7b53d4e12a0a59061fc2673#body_text
is schema:about of	named entity 'clinicians' named entity 'transmission' named entity 'Pandemic' named entity 'Use' named entity 'COVID-19' covid:arg/61abc6624e4d7b6cb7b53d4e12a0a59061fc2673 named entity 'current' named entity 'pandemic' named entity 'key' named entity 'face' named entity 'healthcare systems' named entity 'decision making' named entity 'decision making' named entity 'immunosuppressed' named entity 'AML' named entity 'twitter' named entity 'infection' named entity 'adverse events' named entity 'out-patient' named entity 'prednisolone' named entity 'steroids' named entity 'steroids' named entity 'COVID' named entity 'health care facility' named entity 'targeted therapy' named entity 'cryopreserved' named entity 'cytarabine' named entity 'non-Hodgkins lymphoma' named entity 'hematologic disorders' named entity 'hydroxyurea' named entity 'G-CSF' named entity 'health care personnel' named entity 'Ruxolitinib' named entity 'medicolegal' named entity 'relapse' named entity 'Hematologic Malignancy' named entity 'antifungals' named entity 'mortality rate' named entity 'remission' named entity 'fever' named entity 'polycythemia vera' named entity 'blood products' named entity 'Ibrutinib' named entity 'autologous' named entity 'infection' named entity 'hematologic disorders' named entity 'evidence based' named entity 'immune thrombocytopenia' named entity 'cytarabine' named entity 'COVID' named entity 'cyclosporine' named entity 'platelet transfusion' named entity 'antibiotics' named entity 'androgen' named entity 'autologous' named entity 'primary physician' named entity 'polycythemia vera' named entity 'epidemiology' named entity 'ABVD' named entity 'CNS' named entity 'COVID' named entity 'social isolation' named entity 'infection' named entity 'therapeutic interventions' named entity 'health care personnel' named entity 'corticosteroids' named entity 'World Bank'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software